LUGPA Congressional Fly-In Recap - September 22–23, 2026
Independent Urologists Return to Capitol Hill to Advance Medicare Reform, Protect Access to Cancer Care, and Promote Competition
LUGPA physician leaders representing independent urology practices from across the country traveled to Washington, D.C., September 22–23 for LUGPA’s third Congressional Fly-In of 2026.
| |
 |
| |
LUGPA members and staff in DC. |
| |
 |
| |
LUGPA members meet with Senator James Lankford of Oklahoma in DC. |
| |
 |
| |
LUGPA members meet with staff of representatives in DC. |
Over two days, LUGPA members conducted dozens of meetings with Members of Congress, congressional staff, and key committee offices, advocating for policies that support independent medicine, strengthen Medicare physician payment, protect access to community-based specialty care, and promote competition throughout the healthcare system.
The September Fly-In came at an important time for federal healthcare policy, with Congress considering Medicare physician payment reform while policymakers examine the impact of Medicare drug price negotiation, 340B, hospital consolidation, and site-of-care payment differences. With Congress approaching the fall recess and the 2026 midterm elections ahead, the Fly-In provided an important opportunity to reinforce LUGPA’s priorities with lawmakers and staff before Congress shifts its focus toward the election.
Physicians brought firsthand perspectives from their practices to Capitol Hill, demonstrating how federal payment and regulatory policies affect independent practices and the patients they serve.
LUGPA's Top Advocacy Priorities
1. Sustainable Medicare Physician Payment
LUGPA’s top priority remained reforming the Medicare physician payment system.
Members urged Congress to advance the Provider Reimbursement Stability Act (H.R. 8163/S. 5180) and the bipartisan Patients First Act (H.R. 9693).
Key provisions include:
- Permanent, MEI-based Medicare payment updates
- A higher budget-neutrality threshold
- Regular practice expense updates
- Corrections to utilization estimates for new and revalued codes
- Replacement of MIPS with a physician-led quality framework
- Greater payment predictability for independent practices
The urgency of reform was underscored by CMS’s proposed CY 2027 Medicare Physician Fee Schedule, which includes conversion-factor reductions of approximately 1.19% for qualifying APM participants and 1.68% for non-qualifiers. LUGPA has also opposed CMS’s proposed 50% payment reduction for certain secondary same-day E/M services billed with Modifier 25.
Over the 2001–2026 period, Medicare physician payments increased only approximately 12–15%, while practice costs increased more than 50%. Adjusted for inflation, physician reimbursement has declined by roughly 33%.
LUGPA members emphasized that sustainable payment reform is essential to maintaining physician-led practices, preserving patient access, and ensuring specialty care remains available in community settings.
2. Protecting Access to Community-Based Cancer Care
LUGPA strongly advocated for the Protecting Patient Access to Cancer and Complex Therapies Act (H.R. 4299).
The legislation would protect ASP + 6% reimbursement for physician-administered Part B drugs as Medicare’s drug price negotiation program expands. It would also establish a manufacturer rebate mechanism to address the difference between ASP + 6% and the Maximum Fair Price + 6%, helping protect practices from reimbursement falling below acquisition costs.
For independent urology practices that purchase and administer high-cost therapies, these changes could have significant implications for the ability to continue providing cancer and complex care in community settings.
LUGPA emphasized the importance of ensuring Medicare beneficiaries can continue receiving these treatments close to home rather than facing a shift toward higher-cost hospital settings.
3. 340B Reform, Site-Neutral Payment & Outpatient Care
LUGPA members continued discussions with Congress about 340B transparency and accountability, including:
- SECURE 340B Act (H.R. 9599)
- 340B ACCESS Act (H.R. 5256)
- Tax-Exempt Hospital Transparency Act (H.R. 9504)
Members also discussed the relationship between 340B, hospital acquisition of independent practices, and the migration of care to hospital outpatient settings.
LUGPA supports greater transparency and accountability within the 340B program and clinically appropriate site-neutral payment policies that promote competition and preserve patient choice.
Members also raised concerns about elements of the CY 2027 OPPS/ASC proposed rule that could disadvantage community-based urology practices.
Additional Policy Discussions
Depending on the meeting, LUGPA members also addressed:
- Hospital consolidation and fair competition
- Prior authorization reform, including H.R. 3514
- Medicare Advantage oversight, including downcoding and network adequacy
- AI-driven utilization management
- PBM rebate transparency
- Stark Law modernization, while preserving the In-Office Ancillary Services Exception
These discussions allowed physicians to connect broader healthcare policy debates to the day-to-day realities of providing specialty care in independent practices.
Congressional Engagement
LUGPA members met with offices across both chambers and with key committees of jurisdiction, including Senate Finance, House Ways & Means, and House Energy & Commerce.
Senate
Meetings included offices of:
- Sen. Ron Johnson (R-WI)
- Sen. Mike Crapo (R-ID)
- Sen. Todd Young (R-IN)
- Sen. Steve Daines (R-MT)
- Sen. Josh Hawley (R-MO)
House
Meetings included offices of:
- Rep. Richard Hudson (R-NC)
- Rep. Bob Onder (R-MO)
- Rep. Greg Steube (R-FL)
- Rep. Randy Weber (R-TX)
- Rep. Rudy Yakym (R-IN)
- Rep. Michelle Fischbach (R-MN)
- Rep. Julie Fedorchak (R-ND)
- Rep. Russ Fulcher (R-ID)
- Rep. Bob Latta (R-OH)
- Rep. Eric Sorensen (D-IL)
- Rep. Jamie Raskin (D-MD)
- Rep. Ami Bera (D-CA)
- Rep. Kim Schrier (D-WA)
- Rep. Don Beyer (D-VA)
- Rep. Brittany Pettersen (D-CO)
- Rep. Emanuel Cleaver (D-MO)
- Rep. Sarah Elfreth (D-MD)
LUGPA also participated in fundraising and engagement events with Rep. Adrian Smith (R-NE), Rep. Troy Balderson (R-OH), Rep. Linda Sánchez (D-CA), Sen. James Lankford (R-OK), and Rep. Rob Menendez (D-NJ).
This broad engagement reflects LUGPA’s continued effort to build relationships with policymakers across party lines and provide congressional offices with a direct connection to independent urology practices.
Thank You to Our Participating LUGPA Members
LUGPA extends its sincere thanks to the physician leaders and practice representatives who traveled to Washington, D.C., and took the time to meet with Members of Congress and congressional staff. Their willingness to share their firsthand experiences and speak about the challenges facing independent urology helped bring LUGPA’s policy priorities to life.
Thank you to:
- Erika Ferrozzo — Idaho Urologic Institute
- Dr. Brendan Kramer — Kansas City Urology Care
- Keith Potter — Kansas City Urology Care
- Dr. Scott Sellinger — Advanced Urology Institute, FL
- Dr. Fei Lian — AA Urology, MD
- Dr. Josh Langston — Urology of Virginia
- Dr. Matthew Spellman — Urology of St. Louis
- Jon Sullivan — Urology of St. Louis
Their participation helped demonstrate the importance of ensuring independent, physician-led practices have a voice in the federal policy decisions that affect their practices, their patients, and access to community-based urologic care.
Participating Practices & Support
The September Fly-In was made possible through the leadership and participation of physicians and staff from LUGPA member practices across the country, along with the support of LUGPA advocacy donors.
LUGPA thanks:
- New Jersey Urology
- Jackson Urological Associates
- Wichita Urology
- Unio Specialty Care
- Summit Urology Group
- Urology Clinics of North Texas
- The Urology Group
- Central Ohio Urology Group
- Premier Medical Group of the Hudson Valley
- Urology Associates of Delaware
- Associated Medical Professionals of New York
Their support helps LUGPA bring the voice of independent urology directly to Capitol Hill.
Looking Ahead
LUGPA will continue working with Congress, federal agencies, and coalition partners to advance the priorities discussed during the September Fly-In.
LUGPA’s immediate priorities include:
Part B Drug Access Advance H.R. 4299 to protect access to physician-administered cancer and complex therapies as Medicare drug negotiation expands.
Medicare Payment Reform Advance H.R. 8163/S. 5180 and the Patients First Act (H.R. 9693) to establish more sustainable and predictable physician payment updates.
340B & Site-Neutral Reform Support greater 340B transparency and site-neutral payment policies that promote competition, preserve patient choice, and protect outpatient care.
LUGPA will continue building on the relationships established during the September Fly-In through congressional meetings, coalition advocacy, grassroots engagement, and future Capitol Hill visits throughout the remainder of the 119th Congress.
Your Participation Matters
LUGPA’s Congressional Fly-Ins give independent physicians an opportunity to bring their experiences directly to policymakers and demonstrate how federal healthcare policies affect practices and patients.
These efforts are possible because of the expertise, leadership, and participation of LUGPA members.
We encourage all LUGPA members—and especially participants in our advocacy donor groups—to consider joining a future Congressional Fly-In. Your voice helps strengthen LUGPA’s relationships with lawmakers, raise awareness of the issues facing independent urology, and ensure physician-led practices remain part of the national healthcare policy conversation.
Interested in participating in a future Washington, D.C., Fly-In? Contact Matthew Glans at [email protected].
Together, we can continue advancing policies that preserve physician independence, improve patient access, and strengthen the future of community-based urologic care.
|